GSK puts Monash researcher on Discovery Fast Track

Researchers who have identified potential targets for new medicines for acute myeloid leukaemia (AML) and the autoimmune disease, lupus, have been announced as the two Australian winners of the GSK Discovery Fast Track Challenge.

Dr Kim Good-Jacobson from the Monash Biomedicine Discovery Institute, was a winner of the 2018 GSK Discovery Fast Track Challenge for her research into how to target and destroy antibody producing cells that cause autoimmune diseases.

The winners will be granted rare access to GSK’s state-of-the-art research resources, expertise and compound library to screen their targets to identify molecules that could potentially become new medicines.

The GSK Discovery Fast Track Challenge was designed to help turn innovative research into treatments for patients faster, by fostering greater collaboration between academia and industry. Read more.